课题基金 / 基金详情

TRANSFORMATION OF CELLS BY THE V REL ONCOGENE

TRANSFORMATION OF CELLS BY THE V REL ONCOGENE
V REL 癌基因对细胞的转化
批准号:
6200600
负责人:
THOMAS David GILMORE
金额:
$28.6万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-09-01 至 2004-07-31

项目摘要

项目成果

THOMAS David GILMORE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from investigator's abstract) The Rel/NF-kB family of transcription factors controls a number of genes involved in key cellular processes, such as proliferation, immune and inflammatory responses, and apoptosis. Expression of mutant Rel transcription factors has also been associated with several animal and human cancers. This application explores the mechanism by which an avian retrovirus malignantly transforms and immortalizes avian lymphoid cells, as a model for the molecular basis of certain human lymphoid cancers that are caused by mutant Rel transcription factors. Specific functions of v-Rel that are important for its ability to transform cells will be investigated. These include the ability of mutant Envelope amino acids to endow v-Rel with an N-terminal transactivation domain, the effect of phosphorylation on transaction by v-Rel, and the effect of C0terminal sequences on cytoplasmic localization of c-Rel. the ability of anti-apoptosis proteins in the Bcl-2 family to cooperate in v-Rel-induced oncogenesis will be investigated by creating vectors for the expression of weakly oncogenic Rel proteins and Bcl-2 family members. In a third project, the protein Trip6, which was isolated in a two-hybrid screen with v-Rel, will be characterized. Specifically, requirements for transactivation and subcellular localization of Trip6 will be explored by creating Trip6 knockout mice and cell lines. Finally, cell lines deficient in specific Rel/NF-kappaB family members will be characterized, and these cell lines will be used to analyze the contribution of specific Rel/NJ-kappaB complexes to distinct physiological processes, such as adhesion, growth control, and apoptosis. A long-term goal of this project will be to develop mammalian model systems for studying Rel-mediated oncogenesis, in order to more closely mimic human cancers that involve alterations in Rel transcription factor function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transformation of Cells by the REL Oncogene
ACQUISITION OF A MOLECULAR IMAGER
  • 批准号:
    2286946
  • 项目类别:
  • 资助金额:
    $6.5万
  • 财政年份:
    1996
  • 负责人:
    THOMAS David GILMORE
  • 依托单位:
TRANSFORMATION OF CELLS BY THE V-REL ONCOGENE
  • 批准号:
    2092728
  • 项目类别:
  • 资助金额:
    $14.53万
  • 财政年份:
    1988
  • 负责人:
    THOMAS David GILMORE
  • 依托单位:
TRANSFORMATION OF CELLS BY THE V-REL ONCOGENE
  • 批准号:
    3191543
  • 项目类别:
  • 资助金额:
    $11.44万
  • 财政年份:
    1988
  • 负责人:
    THOMAS David GILMORE
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: